Explain me type 2 hypersensitivity

Reading Document
Medical Text Search

type 2 hypersensitivity antibody-mediated cytotoxic mechanisms

Medical Text Search

type II hypersensitivity clinical examples diseases autoimmune

GradeResponse
GradeResponse

Type 2 Hypersensitivity (Antibody-Mediated Cytotoxic Hypersensitivity)


Overview

Type 2 hypersensitivity is an antibody-mediated, cytotoxic immune reaction in which IgG or IgM antibodies are directed against antigens on the surface of cells or extracellular matrix components. It is distinct from the other hypersensitivity types in that the damage is targeted directly at specific cell-bound or tissue-bound antigens rather than circulating immune complexes or free antigen.

Mechanism

The pathology arises through three main effector pathways:

1. Complement-Mediated Cytotoxicity

  • IgM or IgG (subclasses IgG1, IgG2, IgG3) bind to cell-surface antigens
  • These antibodies fix complement via the classical pathway (starting at C1)
  • This triggers the complement cascade, forming the membrane attack complex (MAC) → direct cell lysis
  • Alternatively, complement fragments (C3b, C4b) act as opsonins, enhancing phagocytosis

2. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)

  • IgG antibodies coat the target cell
  • NK cells, macrophages, and neutrophils recognize the Fc portion of IgG via Fc receptors (FcγRIII / CD16)
  • Effector cells release cytotoxic granules (perforin, granzymes) → target cell death without complement

3. Antibody-Mediated Functional Alteration (Non-cytotoxic subtype)

  • Antibodies bind to receptors or functional molecules on cell surfaces
  • This can either stimulate or block receptor function without causing cell destruction
  • Example: TSH receptor stimulation (Graves' disease) or acetylcholine receptor blockade (Myasthenia gravis)

Key Immunoglobulins Involved

AntibodyRole
IgMMost efficient at activating complement (classical pathway)
IgG1, IgG2, IgG3Complement fixation + ADCC
IgG4Generally does NOT fix complement; may block rather than activate

Classic Clinical Examples

DiseaseTarget AntigenMechanismEffect
ABO-incompatible transfusion reactionRBC surface antigens (A/B)Complement lysisIntravascular hemolysis
Hemolytic disease of the newborn (HDN)Rh (D) antigen on fetal RBCsComplement + ADCCFetal/neonatal hemolysis
Autoimmune hemolytic anemia (AIHA)RBC antigensComplement + opsonizationHemolysis, anemia
Goodpasture's syndromeα3 chain of type IV collagen (GBM)Complement + ADCCGlomerulonephritis + pulmonary hemorrhage
Pemphigus vulgarisDesmoglein 1 & 3 (epidermal cadherins)Antibody disrupts cell adhesionBullous skin lesions, mucosal blistering
Myasthenia gravisNicotinic acetylcholine receptor (nAChR)Receptor blockade + degradationProgressive muscle weakness
Graves' diseaseTSH receptor (TSHR)Receptor stimulation (agonistic Ab)Hyperthyroidism
Immune thrombocytopenic purpura (ITP)Platelet GPIIb/IIIaOpsonization → phagocytosisThrombocytopenia, bleeding
(Based on Harrison's Principles of Internal Medicine, 21st ed., p. 9831 & 9952)

Comparison with Other Hypersensitivity Types

FeatureType IType IIType IIIType IV
MediatorIgEIgG / IgMIgG complexesT cells
Antigen locationSoluble (extracellular)Cell surface / matrixSoluble (circulating)Intracellular / tissue
OnsetMinutesHoursHours–daysDays
Complement involvedNoYes (often)YesNo
ExampleAnaphylaxisGoodpasture'sSLEContact dermatitis

Key Distinguishing Features to Remember

  • "Self vs. non-self on cells" — the antibody attacks something ON a cell surface or in the extracellular matrix
  • Complement fixation is central to most (but not all) type 2 reactions
  • The functional subtype (Graves', Myasthenia gravis) does not destroy cells but alters their function — sometimes classified separately as type 2b or receptor-mediated hypersensitivity
  • Direct Coombs test is positive in type 2 hemolytic reactions (detects antibody/complement on RBCs)
attachment

Explain this

Medical Text Search

type 2 hypersensitivity subtypes opsonization complement dysfunction

GradeResponse
This image is a MedEd study note on Type 2 Hypersensitivity, breaking it into 3 subtypes based on the location of the antibody and the outcome. Here's a full explanation:

Core Concept

Type 2 hypersensitivity is driven by IgG or IgM antibodies reacting against target antigens — often self-antigens (autoantibodies), meaning the body attacks its own components.
The antibody's action leads to 3 distinct mechanisms:

Subtype 1 — Opsonization and Phagocytosis

Mechanism

  • Antibody (IgM or IgG) binds to an antigen on a cell surface (e.g., a red blood cell)
  • This triggers complement activation, producing C3b
  • C3b coats the cell (opsonization)
  • Phagocytes (macrophages) have C3b receptors and Fc receptors → they recognize the coated cell and engulf and destroy it (phagocytosis)

Key Notes from the image

  • IgM always comes with C3 (IgM is very efficient at fixing complement)
  • The macrophage can eat a whole RBC but NOT a whole glomerular membrane → instead it degranulates and activates complement at that site
  • In the spleen, the effector cell is the littoral cell (a specialized macrophage) → it binds to the antibody-coated cell and performs phagocytosis
  • Antibodies against cells → go to spleen → littoral cells handle destruction

Clinical Examples

DiseaseTarget
Autoimmune Hemolytic Anemia (AIHA)Antibodies against RBCs
Immune Thrombocytopenic Purpura (ITP)Antibodies against platelets (GpIb/IX or GpIIb/IIIa)

Subtype 2 — Complement-Mediated Inflammation

Mechanism

  • Antibody binds to antigen on a cell or tissue surface
  • Complement is activated → produces inflammatory fragments
  • WBCs are recruited → they degranulate → attract more WBCs → membrane destruction and inflammation
  • This is complement OR antibody-mediated inflammation of the cell/tissue, NOT necessarily phagocytosis

Pemphigus Vulgaris Example (from handwritten notes)

  1. Ab binds to Ag on skin surface (desmoglein)
  2. Activates complement
  3. Inflammation → desmosomes separated (skin not intact)
  4. Edema forms between layers → bullae/blisters
  • The antigen is indirectly destroyed via bystander inflammatory damage

Clinical Examples

DiseaseTarget
ANCA-mediated vasculitisNeutrophil cytoplasmic antigens → vessel inflammation
Acute rheumatic fever (heart)Cardiac tissue (molecular mimicry with Strep antigens)
Goodpasture's syndromeCollagen type IV in glomerular and alveolar basement membrane

Subtype 3 — Antibody-Mediated Cellular Dysfunction

Mechanism

  • The cell is not destroyed — its function is altered
  • The antibody binds to a receptor on the cell surface
  • This can either:
    • Block the receptor → reduced function
    • Stimulate the receptor → excessive function

Clinical Examples

DiseaseAntibody TargetEffect
Myasthenia gravisNicotinic ACh receptor (nAChR)Blocks receptor → reduced muscle contraction → weakness
Graves' diseaseTSH receptor (TSHR)Stimulates receptor → overproduction of thyroid hormone → hyperthyroidism

Summary Table — 3 Subtypes at a Glance

SubtypeMechanismCell Destroyed?Examples
Opsonization & PhagocytosisAb + C3b coat cell → macrophage eats itYesAIHA, ITP
Complement-mediated InflammationAb activates complement → WBC recruitment → tissue damageYes (via inflammation)Goodpasture's, Rheumatic fever, ANCA vasculitis, Pemphigus
Antibody-mediated DysfunctionAb blocks or stimulates receptorNoMyasthenia gravis, Graves' disease

Personal Note (bottom right of image)

The student summarized it perfectly:
"Type 2 hypersensitivity is because of antibody's action in 3 ways — mechanism for destruction of a cell..."
That's exactly right — the antibody is the common thread, and the 3 subtypes differ only in what happens after it binds.
This is a shared conversation. Sign in to Orris to start your own chat.